04:06

Applications of Electrolytic Cells

08:59

Applications of Galvanic Cells

04:31

Electrolytic Cells

07:29

Galvanic Cells

12:03

Gibbs Free Energy

07:47

Entropy

16:48

Titration of a Weak Acid with a Strong Base

15:42

Titration of a Strong Acid with a Strong Base

04:28

Acid Base Indicators

14:20

How Buffers Work and Buffer Capacity

11:54

Calculating pH of Polyprotic Acids

14:05

Calculations of Weak Acids and Bases

05:01

Understanding the pH and pOH Scales

10:00

FDA approval of TRYVIO - aprocitentan

12:59

discovery of nivasorexant, an orexin-1 receptor antagonist

10:26

FDA approval of REZDIFFRA (resmetirom) for NASH/MASH treatment

03:23

Defining Acids and Bases with Arrhenius and Bronsted Lowry

12:57

Solubility Equilibria

08:23

Le Chatelier's Principle

11:16

FDA approval of EXBLIFEB - cefepime & enmetazobactam

01:15

lead selection & lead optimization - playlist welcome

01:11

preclinical drug safety programs - playlist welcome

16:22

discovery of NX-2127, a BTK degrader for B-cell malignancies

25:03

Using ICE Tables to Calculate Equilibrium Concentrations

07:15

Common Ion Effect

05:54

Reaction Quotient and Equilibrium

04:36

Heterogeneous Equilibrium Expressions

15:09

Writing the Equilibrium Constant

09:58

Calculating the Equilibrium Constant

08:38

Introduction to Equilibrium

11:13

discovery of KIN-3248, a pan-FGFR inhibitor

09:56

sample calculations: oral dose PK parameters

19:40

sample calculations: IV bolus PK parameters

07:03

Enthalpy of Solution

01:13

ADME & pharmacokinetics - playlist welcome

13:21

discovery of JTE-151, a ROR-gamma inhibitor - drug annotation

01:09

measuring drug activity & pharmacodynamics - playlist welcome

16:58

Calorimetry

07:49

Enthalpy of Phase Changes

06:24

Calculations Using Enthalpy of Reaction

04:05

changing poses in drug-target binding

04:35

design of HIV-1 protease inhibitors with x-ray crystallography

04:06

Lipinski's rules & drug discovery beyond the rule of five

04:19

how strong is a hydrogen bond in a drug-target complex?

02:10

fragment-based drug discovery (FBDD) & access to drug research

19:11

3 Methods for Calculating Enthalpy of a Reaction

10:12

Enthalpy and Energy Diagrams

08:43

Introduction to Thermodynamics

03:15

marketing impact of a boxed warning on a drug

03:34

impurites that can lead to drug recalls

02:45

safety risks of food-drug interactions

03:39

reducing hERG activity of a lead compound

02:33

a short history of the United States Food and Drug Administration

03:41

hysteresis curves for visualizing PK/PD relationships

03:58

effect of enterohepatic circulation on drug half-life

02:55

reducing hepatic metabolism to extend a compound's half-life

03:39

rapid drug distribution after IV bolus administration

04:11

role of plasma concentration for understanding drug efficacy

03:34

the importance of observing a dose-response relationship

04:06

the effect of temperature on results of drug assays